振德医疗
(603301)
| 流通市值：51.24亿 | | | 总市值：51.24亿 |
| 流通股本：2.66亿 | | | 总股本：2.66亿 |
| 报告期 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 3,209,194,823.07 | 2,306,140,255.48 | 1,300,476,798.62 | 6,137,634,431.69 |
| 营业收入 | 3,209,194,823.07 | 2,306,140,255.48 | 1,300,476,798.62 | 6,137,634,431.69 |
| 二、营业总成本 | 2,872,608,867.77 | 2,050,535,460.39 | 1,133,257,765.7 | 5,246,611,060.89 |
| 营业成本 | 2,107,276,838.77 | 1,505,111,011.02 | 837,466,371.47 | 3,991,505,377.78 |
| 税金及附加 | 24,362,424.86 | 17,229,357.89 | 11,412,432.41 | 41,797,270.8 |
| 销售费用 | 288,045,540.18 | 216,234,399.16 | 116,083,806.56 | 476,962,381.35 |
| 管理费用 | 371,055,911.82 | 254,127,499.89 | 132,274,439.42 | 507,269,970.21 |
| 研发费用 | 110,447,381.62 | 82,248,238.16 | 42,093,960.5 | 227,002,941.26 |
| 财务费用 | -28,579,229.48 | -24,415,045.73 | -6,073,244.66 | 2,073,119.49 |
| 其中:利息费用 | 23,032,091.48 | 16,479,523.51 | 7,601,281.26 | 33,538,874.49 |
| 其中:利息收入 | 34,375,982.53 | 24,990,291.58 | 13,842,390.11 | 10,608,417.43 |
| 加:公允价值变动收益 | -7,924,950.15 | -13,905,364.24 | 14,606,416.45 | -11,220,407.5 |
| 加:投资收益 | -16,339,617.87 | -8,515,145.35 | -10,597,037.66 | -59,842,333.15 |
| 资产处置收益 | -168,698.73 | -118,174.09 | -283,961.95 | -13,529,835.04 |
| 资产减值损失(新) | -42,333,966.25 | -26,828,049.53 | 25,187.76 | -75,560,492.66 |
| 信用减值损失(新) | 3,782,861.38 | 6,587,886.73 | -1,335,624.79 | -8,597,505.75 |
| 其他收益 | 57,939,006.31 | 51,279,905.4 | 4,083,356.56 | 90,537,130.33 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 331,540,589.99 | 264,105,854.01 | 173,717,369.29 | 812,809,927.03 |
| 加:营业外收入 | 1,052,169.33 | 657,479.81 | 380,980.83 | 1,653,195.31 |
| 减:营业外支出 | 6,096,075.22 | 3,109,259.25 | 2,542,074.27 | 12,746,786.24 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 326,496,684.1 | 261,654,074.57 | 171,556,275.85 | 801,716,336.1 |
| 减:所得税费用 | 17,751,392.99 | 18,823,171.89 | 23,571,134.9 | 98,704,242.06 |
| 六、净利润 | 308,745,291.11 | 242,830,902.68 | 147,985,140.95 | 703,012,094.04 |
| 持续经营净利润 | 308,745,291.11 | 242,830,902.68 | 147,985,140.95 | 703,012,094.04 |
| 归属于母公司股东的净利润 | 300,521,451.57 | 237,366,332.46 | 146,461,478.2 | 681,132,600.36 |
| 少数股东损益 | 8,223,839.54 | 5,464,570.22 | 1,523,662.75 | 21,879,493.68 |
| (一)基本每股收益 | 1.13 | 0.89 | 0.55 | 2.87 |
| (二)稀释每股收益 | 1.13 | 0.89 | 0.55 | 2.87 |
| 八、其他综合收益 | 14,495,161.33 | 36,115,559.21 | 21,144,731.83 | -21,655,764.25 |
| 归属于母公司股东的其他综合收益 | 6,933,104.73 | 20,415,424.3 | 17,972,140.47 | -11,188,849.41 |
| 九、综合收益总额 | 323,240,452.44 | 278,946,461.89 | 169,129,872.78 | 681,356,329.79 |
| 归属于母公司股东的综合收益总额 | 307,454,556.3 | 257,781,756.76 | 164,433,618.67 | 669,943,750.95 |
| 归属于少数股东的综合收益总额 | 15,785,896.14 | 21,164,705.13 | 4,696,254.11 | 11,412,578.84 |
| 公告日期 | 2023-10-31 | 2023-08-30 | 2023-04-26 | 2023-04-26 |
| 审计意见(境内) | | | | 标准无保留意见 |